These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7517796)

  • 21. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
    Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
    Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin resistance in ataxia-telangiectasia.
    Beamish H; Williams R; Chen P; Khanna KK; Hobson K; Watters D; Shiloh Y; Lavin M
    Oncogene; 1996 Sep; 13(5):963-70. PubMed ID: 8806686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ; Chung J; Fiorentino DF; Flanagan WM; Blenis J; Crabtree GR
    Nature; 1992 Jul; 358(6381):70-3. PubMed ID: 1614535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
    Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
    Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes.
    Kim YH; Buchholz MA; Chrest FJ; Nordin AA
    J Immunol; 1994 May; 152(9):4328-35. PubMed ID: 8157956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
    Reddy KB; Hocevar BA; Howe PH
    J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase.
    Lucas JJ; Szepesi A; Domenico J; Takase K; Tordai A; Terada N; Gelfand EW
    Blood; 1995 Sep; 86(6):2268-80. PubMed ID: 7662974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells.
    Simm A; Hoppe V; Karbach D; Leicht M; Fenn A; Hoppe J
    Exp Cell Res; 1998 Nov; 244(2):379-93. PubMed ID: 9806789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
    J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
    Dumont FJ; Fischer P; Sirotina A
    Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
    Kim HS; Raskova J; Degiannis D; Raska K
    Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.